MDS Pharma Services Launches Next Generation Phase I Study Management System
Complete the form below to unlock access to ALL audio articles.
MDS Pharma Services has launched the next generation of its proprietary ClinQuick® electronic system for Phase I study set-up, data capture, project tracking and personnel credential management.
Aimed at improving client service, the new version of the ClinQuick® system extends a 15-year legacy of technical leadership in early clinical research. System enhancements include a more user-friendly interface, improved menu navigation and a more robust data platform. This new platform will enable faster and more flexible reporting and will ultimately allow clients to access their data via the internet.
"Since its implementation in 1993, ClinQuick® has been used successfully in more than 3,000 Phase I studies involving nearly 100,000 participants," said MDS Pharma Services President David Spaight.
"Our investment to enhance the ClinQuick® system builds on that legacy of success and will allow us to meet growing client demand for early clinical research services while maintaining our leadership position in Phase I. This next-generation ClinQuick® system will further improve our ability to deliver high quality Phase I services on time," Spaight added.
